Florida Senate - 2017                        COMMITTEE AMENDMENT
       Bill No. CS for SB 406
       
       
       
       
       
       
                                Ì350518+Î350518                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                   Comm: WD            .                                
                  04/20/2017           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       Appropriations Subcommittee on Health and Human Services
       (Artiles) recommended the following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete lines 914 - 966
    4  and insert:
    5  samples from each final batch or lot of marijuana harvested or
    6  processed to an independent testing laboratory for testing to
    7  ensure, at a minimum, that the labeling of the potency of
    8  tetrahydrocannabinol and all other marketed cannabinoids or
    9  terpenes is accurate and that the marijuana dispensed to
   10  qualifying patients is safe for human consumption.
   11         2. An MMTC must maintain records of all tests conducted,
   12  including the results of each test and any additional
   13  information, as required by the department.
   14         3. The department shall adopt all rules necessary to create
   15  and oversee the quality control program, which must include, at
   16  a minimum:
   17         a. Permissible levels of variation in potency labeling and
   18  standards requiring tetrahydrocannabinol and all other marketed
   19  cannabinoids in edible marijuana products to be distributed
   20  consistently throughout a multiserving product;
   21         b. Permissible levels of contaminants and mandatory testing
   22  for contaminants to confirm that the tested marijuana is safe
   23  for human consumption. This testing must include, but is not
   24  limited to, testing for microbiological impurity, residual
   25  solvents, and pesticide residues;
   26         c. The destruction of marijuana determined to be
   27  inaccurately labeled or unsafe for human consumption after the
   28  MMTC has an opportunity to take remedial action;
   29         d. The collection, storage, handling, recording, and
   30  destruction of samples of marijuana by independent testing
   31  laboratories; and
   32         e. Security, inventory tracking, and record retention.
   33         (b) The department must license all independent testing
   34  laboratories to ensure that all marijuana is tested for potency
   35  and contaminants in accordance with the department’s quality
   36  control program. An independent testing laboratory may collect
   37  and accept samples of, and possess, store, transport, and test,
   38  marijuana. An independent testing laboratory may not be owned by
   39  a person who also possesses an ownership interest in an MMTC.
   40         1. The department shall develop rules establishing
   41  independent testing laboratory license requirements and a
   42  process for licensing independent testing laboratories; develop
   43  an application form for an independent testing laboratory
   44  license; and impose an initial application fee and a biennial
   45  renewal fee sufficient to cover the costs of administering this
   46  subsection.
   47         2. In addition to licensure, an independent testing
   48  laboratory must be certified to perform all required tests by
   49  the department. An independent testing laboratory must obtain
   50  certification from the department or from a third-party
   51  laboratory certification body approved by the department. The
   52  department shall establish reasonable rules for
   53  
   54  ================= T I T L E  A M E N D M E N T ================
   55  And the title is amended as follows:
   56         Delete line 68
   57  and insert:
   58         treatment centers to submit samples from each final
   59         batch or